1. Executive Summary
1.1. Global Oligonucleotide Synthesis Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Oligonucleotide Synthesis Market Outlook, 2018 - 2031
3.1. Global Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Universal Oligonucleotide Synthesis
3.1.1.2. Custom Oligonucleotide Synthesis
3.2. Global Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Academic R&D
3.2.1.2. Commercial R&D
3.3. Global Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Biopharmaceutical Companies
3.3.1.2. Academic & Research Institutes
3.3.1.3. Contract Research Organizations
3.4. Global Oligonucleotide Synthesis Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Oligonucleotide Synthesis Market Outlook, 2018 - 2031
4.1. North America Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Universal Oligonucleotide Synthesis
4.1.1.2. Custom Oligonucleotide Synthesis
4.2. North America Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Academic R&D
4.2.1.2. Commercial R&D
4.3. North America Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Biopharmaceutical Companies
4.3.1.2. Academic & Research Institutes
4.3.1.2.1. Contract Research Organizations
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
4.4.1.2. U.S. Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
4.4.1.3. U.S. Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
4.4.1.4. Canada Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
4.4.1.5. Canada Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
4.4.1.6. Canada Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Oligonucleotide Synthesis Market Outlook, 2018 - 2031
5.1. Europe Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Universal Oligonucleotide Synthesis
5.1.1.2. Custom Oligonucleotide Synthesis
5.2. Europe Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Academic R&D
5.2.1.2. Commercial R&D
5.3. Europe Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Biopharmaceutical Companies
5.3.1.2. Academic & Research Institutes
5.3.2. Contract Research Organizations
5.4. Europe Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.2. Germany Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.3. Germany Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.4. U.K. Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.5. U.K. Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.6. U.K. Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.7. France Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.8. France Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.9. France Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.10. Italy Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.11. Italy Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.12. Italy Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.13. Turkey Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.14. Turkey Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.15. Turkey Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.16. Russia Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.17. Russia Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.18. Russia Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.19. Rest of Europe Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
5.4.1.20. Rest of Europe Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.21. Rest of Europe Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Oligonucleotide Synthesis Market Outlook, 2018 - 2031
6.1. Asia Pacific Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Universal Oligonucleotide Synthesis
6.1.1.2. Custom Oligonucleotide Synthesis
6.2. Asia Pacific Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Academic R&D
6.2.1.2. Commercial R&D
6.3. Asia Pacific Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Biopharmaceutical Companies
6.3.1.2. Academic & Research Institutes
6.3.1.2.1. Contract Research Organizations
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.2. China Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.3. China Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.4. Japan Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.5. Japan Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.6. Japan Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.7. South Korea Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.8. South Korea Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.9. South Korea Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.10. India Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.11. India Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.12. India Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.13. Southeast Asia Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.14. Southeast Asia Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.15. Southeast Asia Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Oligonucleotide Synthesis Market Outlook, 2018 - 2031
7.1. Latin America Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Universal Oligonucleotide Synthesis
7.1.1.2. Custom Oligonucleotide Synthesis
7.2. Latin America Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Academic R&D
7.2.1.2. Commercial R&D
7.3. Latin America Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Biopharmaceutical Companies
7.3.1.2. Academic & Research Institutes
7.3.1.2.1. Contract Research Organizations
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
7.4.1.2. Brazil Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.3. Brazil Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.4. Mexico Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
7.4.1.5. Mexico Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.6. Mexico Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.7. Argentina Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
7.4.1.8. Argentina Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.9. Argentina Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.10. Rest of Latin America Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
7.4.1.11. Rest of Latin America Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.12. Rest of Latin America Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Oligonucleotide Synthesis Market Outlook, 2018 - 2031
8.1. Middle East & Africa Oligonucleotide Synthesis Market Outlook, by Service Type, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Universal Oligonucleotide Synthesis
8.1.1.2. Custom Oligonucleotide Synthesis
8.2. Middle East & Africa Oligonucleotide Synthesis Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Academic R&D
8.2.1.2. Commercial R&D
8.3. Middle East & Africa Oligonucleotide Synthesis Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Biopharmaceutical Companies
8.3.1.2. Academic & Research Institutes
8.3.1.2.1. Contract Research Organizations
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Oligonucleotide Synthesis Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.2. GCC Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.3. GCC Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.4. South Africa Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.5. South Africa Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.6. South Africa Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.7. Egypt Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.8. Egypt Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.9. Egypt Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.10. Nigeria Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.11. Nigeria Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.12. Nigeria Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Oligonucleotide Synthesis Market by Service Type, Value (US$ Mn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Oligonucleotide Synthesis Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Oligonucleotide Synthesis Market by End User, Value (US$ Mn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs By Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Integrated DNA Technologies, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. GenScript Biotech Corporation
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Eurofins Scientific SE
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Bioneer Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Kaneka Corporation (Eurogentec)
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Biolegio B.V.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Eton Bioscience, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. IBA GmbH
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Quintara Biosciences
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. LGC Biosearch Technologies
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Thermo Fisher Scientific, Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. TriLink BioTechnologies, LLC
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. TAG Copenhagen A/S
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. PolyGen GmbH
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. General Electric Co
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. BioAutomation
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. Biolytic Lab Performance Inc.
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations